XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Net Loss and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
REVENUES        
Total revenues $ 20,751 $ 10,797 $ 41,002 $ 21,283
OPERATING COSTS AND EXPENSES        
Cost of goods sold 4,649 1,140 6,732 2,972
License royalties   100   100
Research and development 12,055 26,420 25,473 49,332
Selling, general, and administrative 11,270 23,082 23,521 36,520
Total operating costs and expenses 27,974 50,742 55,726 88,924
Loss from operations (7,223) (39,945) (14,724) (67,641)
OTHER INCOME / (LOSS), NET        
Interest and other income/(loss) 1,100 (1,186) 2,211 (1,558)
LOSS BEFORE INCOME TAXES (6,123) (41,131) (12,513) (69,199)
Provision for income taxes 179   179  
NET LOSS (6,302) (41,131) (12,692) (69,199)
Other comprehensive income/(loss)        
Foreign currency translation 18 1,422 (288) 1,733
COMPREHENSIVE LOSS $ (6,284) $ (39,709) $ (12,980) $ (67,466)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.14) $ (0.94) $ (0.29) $ (1.58)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.14) $ (0.94) $ (0.29) $ (1.58)
Weighted average common shares outstanding, basic (in shares) 43,663,112 43,718,748 43,667,385 43,713,967
Weighted average common shares outstanding, diluted (in shares) 43,663,112 43,718,748 43,667,385 43,713,967
Product        
REVENUES        
Total revenues $ 20,751 $ 9,797 $ 41,002 $ 20,283
License        
REVENUES        
Total revenues   $ 1,000   $ 1,000